Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-04-08 Sale | 2024-04-10 8:53 pm | MADRIGAL PHARMACEUTICALS INC. | MDGL | Taub Rebecca Pres., R&D, and CMO | 2,676 | $245.99 | $658,258 | 1,191,103 (Indirect Direct) | View |
| 2024-04-03 Sale | 2024-04-05 8:50 pm | MADRIGAL PHARMACEUTICALS INC. | MDGL | Taub Rebecca Pres., R&D, and CMO | 73,888 | $243.92 | $18,022,588 | 1,425,808 (Indirect Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-04-08 Exercise | 2024-04-10 8:53 pm | N/A 2026-07-22 | MADRIGAL PHARMACEUTICALS INC. | MDGL | Taub Rebecca Pres., R&D, and CMO | 2,676 | $0 | 1,191,103 (Direct) | View |
| 2024-04-08 Exercise | 2024-04-10 8:53 pm | N/A N/A | MADRIGAL PHARMACEUTICALS INC. | MDGL | Taub Rebecca Pres., R&D, and CMO | 2,676 | $9.45 | 1,191,103 (Direct) | View |
| 2024-04-03 Exercise | 2024-04-05 8:50 pm | N/A 2026-07-22 | MADRIGAL PHARMACEUTICALS INC. | MDGL | Taub Rebecca Pres., R&D, and CMO | 73,888 | $0 | 1,425,808 (Direct) | View |
| 2024-04-03 Exercise | 2024-04-05 8:50 pm | N/A N/A | MADRIGAL PHARMACEUTICALS INC. | MDGL | Taub Rebecca Pres., R&D, and CMO | 73,888 | $9.45 | 1,425,808 (Direct) | View |
| 2024-01-23 Option Award | 2024-01-25 5:54 pm | N/A 2031-01-23 | MADRIGAL PHARMACEUTICALS INC. | MDGL | Taub Rebecca Pres., R&D, and CMO | 14,504 | $0 | 1,129,043 (Direct) | View |
| 2024-01-16 Tax Withholding | 2024-01-18 1:46 pm | N/A N/A | MADRIGAL PHARMACEUTICALS INC. | MDGL | Taub Rebecca Pres., R&D, and CMO | 1,546 | $243.92 | 1,108,753 (Direct) | View |
| 2023-01-16 Option Award | 2023-01-18 8:00 pm | N/A N/A | MADRIGAL PHARMACEUTICALS INC. | MDGL | Taub Rebecca Pres., R&D, and CMO | 20,001 | $0 | 1,110,299 (Direct) | View |
Ownership | 2022-08-01 4:10 pm | 2021-03-29 2026-03-29 | BriaCell Therapeutics Corp. | BCTX | Taub Rebecca Director | 0 | $0 | 20,000 (Direct) | View |
| 2022-02-22 Option Award | 2022-02-24 8:12 pm | N/A 2032-02-22 | MADRIGAL PHARMACEUTICALS INC. | MDGL | Taub Rebecca See Remarks | 61,500 | $0 | 61,500 (Direct) | View |
| 2021-02-22 Option Award | 2021-02-23 1:28 pm | N/A 2031-02-22 | MADRIGAL PHARMACEUTICALS INC. | MDGL | Taub Rebecca See Remarks | 44,000 | $0 | 44,000 (Direct) | View |
| 2020-03-05 Option Award | 2020-03-05 5:02 pm | N/A 2030-03-05 | MADRIGAL PHARMACEUTICALS INC. | MDGL | Taub Rebecca Pres., R&D, and CMO | 44,000 | $0 | 44,000 (Direct) | View |
| 2019-07-10 Option Award | 2019-07-11 11:28 am | N/A 2029-07-10 | MADRIGAL PHARMACEUTICALS INC. | MDGL | Taub Rebecca President of R&D | 8,000 | $0 | 8,000 (Direct) | View |